IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
32 hedge funds and large institutions have $22.3M invested in Impel Pharmaceuticals Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
–
Holders Change %
0%
% of All Funds
0.5%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
2
Increased
4
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $1.66K | – | – | – |
|
27
Osaic Holdings
Scottsdale,
Arizona
| $730 | – | – | – |
|
28
JPMorgan Chase & Co
New York
| $456 | -$3.43K | -2,700 | -88% |
|
29
Wells Fargo
San Francisco,
California
| $94 | +$4 | +3 | +4% |
|
|
NC
30
NewSquare Capital
Newtown Square,
Pennsylvania
| $25 | – | – | – |
|
31
Bank of America
Charlotte,
North Carolina
| $2 | – | – | – |
|
32
Millennium Management
New York
| – | -$41K | -29,401 | Closed |
|
33
Renaissance Technologies
New York
| – | -$17K | -12,300 | Closed |
|